H.R. 4101
119th Congress
Cancer Drug Parity Act of 2025
27
Cosponsors
3
Actions
0
Amendments
0
Committees
—
Since introduced
Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action
Referred to the House Committee on Education and Workforce.
24 juin 2025·1 year ago
Timeline
3 actions
Referred to the House Committee on Education and Workforce.
24 juin 2025 · IntroReferral
Introduced in House
24 juin 2025 · IntroReferral
Introduced in House
24 juin 2025 · IntroReferral
Sponsorship
27 cosponsors
Sponsor
Republican:Rep. Grothman, Glenn [R-WI-6]WICosponsors
- Democrat2281%
- Republican519%
- Republican:Rep. Schmidt, Derek [R-KS-2]KS
- Democrat:Rep. Pappas, Chris [D-NH-1]NH
- Democrat:Rep. Neguse, Joe [D-CO-2]CO
- Democrat:Rep. Conaway, Herbert C. [D-NJ-3]NJ
- Democrat:Rep. Salinas, Andrea [D-OR-6]OR
- Democrat:Rep. Bynum, Janelle S. [D-OR-5]OR
- Democrat:Rep. Jackson, Jonathan L. [D-IL-1]IL
- Democrat:Rep. Houlahan, Chrissy [D-PA-6]PA
- Democrat:Rep. Garamendi, John [D-CA-8]CA
- Democrat:Rep. Ross, Deborah K. [D-NC-2]NC
- Democrat:Rep. Vindman, Eugene Simon [D-VA-7]VA
- Republican:Rep. Bresnahan, Robert P. [R-PA-8]PA
- Democrat:Rep. Balint, Becca [D-VT-At Large]VT
- Democrat:Del. Norton, Eleanor Holmes [D-DC-At Large]DC
- Democrat:Rep. Raskin, Jamie [D-MD-8]MD
- Democrat:Rep. Castor, Kathy [D-FL-14]FL
- Democrat:Rep. Kennedy, Timothy M. [D-NY-26]NY
- Democrat:Rep. Bonamici, Suzanne [D-OR-1]OR
- Democrat:Rep. Matsui, Doris O. [D-CA-7]CA
- Republican:Rep. Wilson, Joe [R-SC-2]SC
- Democrat:Rep. Morelle, Joseph D. [D-NY-25]NY
- Republican:Rep. Fitzpatrick, Brian K. [R-PA-1]PA
- Democrat:Rep. Davis, Donald G. [D-NC-1]NC
- Republican:Rep. Bilirakis, Gus M. [R-FL-12]FL
- Democrat:Rep. Brownley, Julia [D-CA-26]CA
- Democrat:Rep. Moore, Gwen [D-WI-4]WI
- Democrat:Rep. Davids, Sharice [D-KS-3]KS
Classification
Policy area
HealthCosponsor momentum
Cumulative over time
Cosponsors grew from 10 on 24 juin 2025 to 27 on 16 mars 2026.
Track Cancer Drug Parity Act of 2025 as it moves through Congress
Get alerts on votes, amendments, and stock-market impact